Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Express Scripts
McKesson
Dow
Mallinckrodt

Last Updated: January 23, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Dengue vaccine


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Dengue vaccine?

Dengue vaccine is an investigational drug.

There have been 13 clinical trials for Dengue vaccine. The most recent clinical trial was a Phase 2 trial, which was initiated on September 7th 2016.

The most common disease conditions in clinical trials are Dengue, COVID-19, and Encephalitis, Japanese. The leading clinical trial sponsors are Takeda, Kafrelsheikh University, and University of Birmingham.

There are nine US patents protecting this investigational drug and one hundred and thirty international patents.

Recent Clinical Trials for Dengue vaccine
TitleSponsorPhase
Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety.Kafrelsheikh UniversityPhase 1/Phase 2
Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative TreatmentDamietta UniversityPhase 2
Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative TreatmentKafrelsheikh UniversityPhase 2

See all Dengue vaccine clinical trials

Clinical Trial Summary for Dengue vaccine

Top disease conditions for Dengue vaccine
Top clinical trial sponsors for Dengue vaccine

See all Dengue vaccine clinical trials

US Patents for Dengue vaccine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Dengue vaccine ⤷  Try it Free Process for preparing an attenuated tetravalent dengue vaccine Fundacao Butantan (Sao Paulo, BR) ⤷  Try it Free
Dengue vaccine ⤷  Try it Free Process for preparing an attenuated tetravalent dengue vaccine Fundacao Butantan (Sao Paulo, BR) ⤷  Try it Free
Dengue vaccine ⤷  Try it Free Tetravalent dengue vaccine INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY (New Delhi, IN) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Express Scripts
McKesson
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.